• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2023

Year: 2023

Stock News

Seres Therapeutics: FDA Approval Straight Ahead (NASDAQ:MCRB)

February 6, 2023 admin 0

Bet_Noire Tact is the knack of making a point without making an enemy.”― Isaac Newton. Today, we put Seres Therapeutics, Inc. (NASDAQ:MCRB) in the spotlight. If all goes well, the company will garner its first […]

No Picture
Stock News

Cummins Inc. (CMI) Q4 2022 Earnings Call Transcript

February 6, 2023 admin 0

Cummins Inc. (NYSE:CMI) Q4 2022 Results Conference Call February 6, 2023 10:00 AM ET Company Participants Chris Clulow – VP, IR Jennifer Rumsey – President and CEO Mark Smith – CFO Conference Call Participants Jerry […]

Stock News

Tesla Approaches Being A Peter Lynch Stock (NASDAQ:TSLA)

February 6, 2023 admin 0

phototechno Thesis Peter Lynch probably is best known for picking 10 baggers. In his writings (e.g., Beating the Street is my favorite one), he divided stocks into 6 categories ranging from stalwarts, to turnarounds, to […]

Posts navigation

« 1 … 1,473 1,474 1,475 … 4,581 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • United Airlines Holdings Earnings, Revenue Beat in Q3 By Investing.com
    October 19, 2021 0
  • OPEC Drops The Bombshell | Seeking Alpha
    October 5, 2022 0
  • UK Inflation Soars in December, GBP/USD Underpinned by Strong UK Data Releases
    January 19, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.